TY - JOUR PY - 2017// TI - Metacognitive therapy in major depression: an open trial of comorbid cases JO - Cognitive and behavioral practice A1 - Hjemdal, Odin A1 - Hagen, Roger A1 - Solem, Stian A1 - Nordahl, Henrik A1 - Kennair, Leif Edward Ottesen A1 - Ryum, Truls A1 - Nordahl, Hans M. A1 - Wells, Adrian SP - 312 EP - 318 VL - 24 IS - 3 N2 - This open trial investigated the transdiagnostic effects of metacognitive therapy (MCT) in patients with severe major depressive disorder and comorbid psychiatric disorder. Ten patients were treated with MCT over 10 sessions and were assessed with measures of depression, anxiety, rumination, and metacognitions at pre- and posttreatment and at 6 months follow-up. None of the patients were diagnosed as depressed at posttreatment, and of the initial 21 total diagnoses at pretreatment only 3 diagnoses remained at postintervention. The effect sizes were large for symptoms of depression, rumination, and worry. At 6 months follow-up standardized recovery criteria on the BDI showed that 70% were recovered, 20% improved, and 10% unchanged. The results indicate that MCT was associated with high rates of transdiagnostic improvement.
Language: en
LA - en SN - 1077-7229 UR - http://dx.doi.org/10.1016/j.cbpra.2016.06.006 ID - ref1 ER -